|
Volumn 20, Issue 1, 2010, Pages 77-82
|
Calcium antagonists: current and future applications based on new evidence. Calcium antagonists and diabetes
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADVANCED GLYCATION END PRODUCT;
ANTIOXIDANT;
CALCIUM CHANNEL BLOCKING AGENT;
MITOGEN ACTIVATED PROTEIN KINASE;
NIFEDIPINE;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;
RAGE PROTEIN, HUMAN;
TUMOR ANTIGEN;
BIOSYNTHESIS;
DIABETIC ANGIOPATHY;
DIABETIC NEPHROPATHY;
DIABETIC RETINOPATHY;
DRUG ANTAGONISM;
HUMAN;
HYPERTENSION;
METABOLISM;
REVIEW;
ANTIGENS, NEOPLASM;
ANTIOXIDANTS;
CALCIUM CHANNEL BLOCKERS;
DIABETIC ANGIOPATHIES;
DIABETIC NEPHROPATHIES;
DIABETIC RETINOPATHY;
GLYCOSYLATION END PRODUCTS, ADVANCED;
HUMANS;
HYPERTENSION;
MITOGEN-ACTIVATED PROTEIN KINASES;
NIFEDIPINE;
PPAR GAMMA;
|
EID: 77951625578
PISSN: 09175857
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (2)
|
References (14)
|